These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34266915)

  • 1. How Cancer Risk SNPs May Contribute to Prostate Cancer Disparities.
    Mavura MY; Huang FW
    Cancer Res; 2021 Jul; 81(14):3764-3765. PubMed ID: 34266915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility-Associated Genetic Variation in
    Han D; Owiredu JN; Healy BM; Li M; Labaf M; Steinfeld JS; Patalano S; Gao S; Liu M; Macoska JA; Zarringhalam K; Siegfried KR; Yuan X; Rebbeck TR; Cai C
    Cancer Res; 2021 Jul; 81(14):3766-3776. PubMed ID: 33632899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
    Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models.
    Woods-Burnham L; Basu A; Cajigas-Du Ross CK; Love A; Yates C; De Leon M; Roy S; Casiano CA
    Prostate; 2017 Dec; 77(16):1601-1608. PubMed ID: 29030865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
    Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
    Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of
    Lin HY; Callan CY; Fang Z; Tung HY; Park JY
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in prostate cancer: a molecular perspective.
    Bhardwaj A; Srivastava SK; Khan MA; Prajapati VK; Singh S; Carter JE; Singh AP
    Front Biosci (Landmark Ed); 2017 Jan; 22(5):772-782. PubMed ID: 27814645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
    Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Hsing AW; Nemesure B; Rebbeck TR; Cooney KA; Xu J; Kibel AS; Hu JJ; John EM; Gueye SM; Watya S; Signorello LB; Hayes RB; Wang Z; Yeboah E; Tettey Y; Cai Q; Kolb S; Ostrander EA; Zeigler-Johnson C; Yamamura Y; Neslund-Dudas C; Haslag-Minoff J; Wu W; Thomas V; Allen GO; Murphy A; Chang BL; Zheng SL; Leske MC; Wu SY; Ray AM; Hennis AJ; Thun MJ; Carpten J; Casey G; Carter EN; Duarte ER; Xia LY; Sheng X; Wan P; Pooler LC; Cheng I; Monroe KR; Schumacher F; Le Marchand L; Kolonel LN; Chanock SJ; Van Den Berg D; Stram DO; Henderson BE
    Nat Genet; 2011 Jun; 43(6):570-3. PubMed ID: 21602798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphB2 SNPs and sporadic prostate cancer risk in African American men.
    Robbins CM; Hooker S; Kittles RA; Carpten JD
    PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer in African American men.
    Patierno SR
    Clin Adv Hematol Oncol; 2020 Mar; 18(3):154-156. PubMed ID: 32609663
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.
    Beebe-Dimmer JL; Zuhlke KA; Ray AM; Lange EM; Cooney KA
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):362-8. PubMed ID: 20697428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.
    Karunamuni RA; Huynh-Le MP; Fan CC; Thompson W; Eeles RA; Kote-Jarai Z; Muir K; ; Lophatananon A; Tangen CM; Goodman PJ; Thompson IM; Blot WJ; Zheng W; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Park JY; Lin HY; Bensen JT; Fontham ETH; Mohler JL; Taylor JA; Multigner L; Blanchet P; Brureau L; Romana M; Leach RJ; John EM; Fowke J; Bush WS; Aldrich M; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Parent MÉ; Hu JJ; Sanderson M; Mills IG; Andreassen OA; Dale AM; Seibert TM;
    Int J Cancer; 2021 Jan; 148(1):99-105. PubMed ID: 32930425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans.
    Hooker S; Bonilla C; Akereyeni F; Ahaghotu C; Kittles RA
    Prostate Cancer Prostatic Dis; 2008; 11(4):349-56. PubMed ID: 18026184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.